Richard Silfen

Practice Areas

Mr. Silfen practices in the area of corporate law, and regularly advises companies and their boards, as well as fund sponsors and their portfolio companies, in capital markets and other capital-raising transactions, mergers and acquisitions and control transactions.

Mr. Silfen also assists emerging and private equity-backed companies to develop plans for the growth and development of their businesses and technologies, including collaborative and strategic partnerships, and joint venture arrangements. His practice focuses include the healthcare/life sciences, fintech, cannabis and real estate sectors.

Mr. Silfen also assists emerging and private equity-backed companies to develop plans for the growth and development of their businesses and technologies, including collaborative and strategic partnerships, and joint venture arrangements. His practice focuses include the healthcare/life sciences, fintech, cannabis and real estate sectors.

Career

Duane Morris LLP: Partner, 2007-2014, 2015-present; VEREIT, Inc.: Executive Vice President, General Counsel and Secretary, 2014-2015; Cangen Biotechnologies, Inc.: President and Chief Financial Officer, 2004-2006; Morgan, Lewis & Bockius LLP: Partner, 2000-2004; Wolf, Block, Schorr and Solis-Cohen LLP: Vice Chairman, Corporate Department, 1999-2000, Partner, 1996-2000; Securities & Exchange Commission, Division of Corporation Finance, 1987-90: Staff Attorney, Office of Chief Counsel and Office of Mergers and Acquisitions, Attorney-Adviser, Disclosure Operations Office

Professional Memberships

GMH Communities Trust; Chairman, Nominating and Governance Committee of Board of Trustees; Drexel University Thomas R. Kline School of Law, Private Equity and Venture Capital Law, Adjunct Professor

Personal

The University of Alabama School of Law, J.D., 1987; Baylor University, B.A. (Physics), 1983